Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to -$1.1 million.

  • Neuronetics' Change in Accured Expenses fell 14860.92% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 40308.91%. This contributed to the annual value of -$2.1 million for FY2024, which is 713.33% up from last year.
  • Latest data reveals that Neuronetics reported Change in Accured Expenses of -$1.1 million as of Q3 2025, which was down 14860.92% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Change in Accured Expenses ranged from a high of $3.3 million in Q4 2022 and a low of -$7.7 million during Q1 2023
  • Moreover, its 5-year median value for Change in Accured Expenses was $1.2 million (2023), whereas its average is -$6000.0.
  • Per our database at Business Quant, Neuronetics' Change in Accured Expenses surged by 64830.19% in 2021 and then tumbled by 161812.08% in 2023.
  • Neuronetics' Change in Accured Expenses (Quarter) stood at $1.3 million in 2021, then skyrocketed by 154.3% to $3.3 million in 2022, then decreased by 23.5% to $2.6 million in 2023, then crashed by 135.85% to -$917000.0 in 2024, then fell by 16.25% to -$1.1 million in 2025.
  • Its Change in Accured Expenses was -$1.1 million in Q3 2025, compared to $1.3 million in Q2 2025 and -$3.5 million in Q1 2025.